Conclusions A USF1/HKDC1/SMS axis couples polyamine metabolism to immune dysfunction and lenvatinib resistance
HW prepared and wrote the original manuscript and was responsible for oversight and project management
Ask Our Experts Call, text, chat, or email for a free personalized risk assessment on exposures in pregnancy and breastfeeding.
Always consult with qualified healthcare providers before starting any weight loss program or medication
PurpleLab, using its healthcare claims database and HealthNexus analytics platform, analyzed medical and pharmacy claims for 12.2M people taking GLP-1 medications from January 2019 May 2024
Petersen N, Reimann F, van Es JH, van den Berg BM, Kroone C, Pais R, et al